000301549 001__ 301549
000301549 005__ 20250524113308.0
000301549 0247_ $$2doi$$a10.2340/1651-226X.2025.43028
000301549 0247_ $$2pmid$$apmid:40402041
000301549 0247_ $$2ISSN$$a0284-186X
000301549 0247_ $$2ISSN$$a0348-5196
000301549 0247_ $$2ISSN$$a0567-8056
000301549 0247_ $$2ISSN$$a0567-8064
000301549 0247_ $$2ISSN$$a1100-1704
000301549 0247_ $$2ISSN$$a1651-226X
000301549 0247_ $$2ISSN$$a1651-2499
000301549 037__ $$aDKFZ-2025-01070
000301549 041__ $$aEnglish
000301549 082__ $$a610
000301549 1001_ $$aToussaint, Laura$$b0
000301549 245__ $$aEuropean practice on neurovascular late effects after pediatric radiotherapy: considerations on dose planning and follow-up - a HARMONIC/SIOPE ROWG survey.
000301549 260__ $$aAbingdon$$bTaylor & Francis Group$$c2025
000301549 3367_ $$2DRIVER$$aarticle
000301549 3367_ $$2DataCite$$aOutput Types/Journal article
000301549 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1748004753_17488
000301549 3367_ $$2BibTeX$$aARTICLE
000301549 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000301549 3367_ $$00$$2EndNote$$aJournal Article
000301549 520__ $$aThe risk of developing neurovascular late effects after radiotherapy is an area of concern when treating pediatric brain tumor patients. However, knowledge is sparse regarding best practice for clinical management during the radiotherapy (RT) planning process and follow-up examinations. This study therefore aimed at mapping how the risk of neurovascular late effects is considered for pediatric brain or skull base tumor patients treated with radiotherapy in Europe.Two web-based surveys ‑ a RT and a pediatric oncology (PO) survey - were distributed to members of the SIOPE radiotherapy working group or PANCARE and SIOPE brain tumor group, respectively.The RT survey was completed by 47 participants from 18 different European countries and the PO survey by 33 participants (mostly pediatric (neuro)oncologists) from 15 countries. Overall, the answers highlighted that neurovascular late effects are currently not well included in European clinical practice, neither at the time of radiotherapy nor in the follow-up process.There is a need for raising general awareness about the topic, as well as for potential risk-stratified prevention measures and follow-up guidelines.
000301549 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000301549 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000301549 650_2 $$2MeSH$$aHumans
000301549 650_2 $$2MeSH$$aEurope
000301549 650_2 $$2MeSH$$aChild
000301549 650_2 $$2MeSH$$aFollow-Up Studies
000301549 650_2 $$2MeSH$$aBrain Neoplasms: radiotherapy
000301549 650_2 $$2MeSH$$aRadiotherapy Planning, Computer-Assisted: methods
000301549 650_2 $$2MeSH$$aRadiation Injuries: etiology
000301549 650_2 $$2MeSH$$aRadiation Injuries: prevention & control
000301549 650_2 $$2MeSH$$aRadiation Injuries: epidemiology
000301549 650_2 $$2MeSH$$aSurveys and Questionnaires
000301549 650_2 $$2MeSH$$aRadiotherapy Dosage
000301549 650_2 $$2MeSH$$aSkull Base Neoplasms: radiotherapy
000301549 650_2 $$2MeSH$$aPractice Patterns, Physicians': statistics & numerical data
000301549 650_2 $$2MeSH$$aFemale
000301549 650_2 $$2MeSH$$aMale
000301549 7001_ $$aTram Henriksen, Louise$$b1
000301549 7001_ $$aVan Beek, Karen$$b2
000301549 7001_ $$aBolle, Stephanie$$b3
000301549 7001_ $$aDemoor-Goldschmidt, Charlotte$$b4
000301549 7001_ $$aGains, Jenny$$b5
000301549 7001_ $$aHøyer, Morten$$b6
000301549 7001_ $$aJanssens, Geert O$$b7
000301549 7001_ $$aKortmann, Rolf-Dieter$$b8
000301549 7001_ $$aMartins Pedro, Catia$$b9
000301549 7001_ $$0P:(DE-HGF)0$$aTimmermann, Beate$$b10
000301549 7001_ $$aScheinemann, Katrin$$b11
000301549 7001_ $$aLassen-Ramshad, Yasmin$$b12
000301549 773__ $$0PERI:(DE-600)1492623-4$$a10.2340/1651-226X.2025.43028$$gVol. 64, p. 703 - 707$$p703 - 707$$tActa oncologica$$v64$$x0284-186X$$y2025
000301549 909CO $$ooai:inrepo02.dkfz.de:301549$$pVDB
000301549 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000301549 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000301549 9141_ $$y2025
000301549 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-11$$wger
000301549 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-11
000301549 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-11
000301549 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-08-13T06:17:08Z
000301549 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-08-13T06:17:08Z
000301549 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-08-13T06:17:08Z
000301549 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2024-08-13T06:17:08Z
000301549 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-11
000301549 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-11
000301549 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-11
000301549 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-11
000301549 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-11
000301549 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-11
000301549 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-11
000301549 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-11
000301549 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-11
000301549 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bACTA ONCOL : 2022$$d2024-12-11
000301549 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-11
000301549 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-11
000301549 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-11
000301549 9201_ $$0I:(DE-He78)ED01-20160331$$kED01$$lDKTK Koordinierungsstelle Essen/Düsseldorf$$x0
000301549 980__ $$ajournal
000301549 980__ $$aVDB
000301549 980__ $$aI:(DE-He78)ED01-20160331
000301549 980__ $$aUNRESTRICTED